Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.520
-0.070 (-4.40%)
Feb 12, 2026, 4:00 PM EST - Market closed

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $2.20M in the quarter ending September 30, 2025, with 8.60% growth. This brings the company's revenue in the last twelve months to $9.30M, down -19.00% year-over-year. In the year 2024, Caribou Biosciences had annual revenue of $9.99M, down -71.01%.

Revenue (ttm)
$9.30M
Revenue Growth
-19.00%
P/S Ratio
15.13
Revenue / Employee
$63,231
Employees
147
Market Cap
142.07M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.99M-24.48M-71.01%
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sangamo Therapeutics32.88M
ProQR Therapeutics18.86M
Innate Pharma14.84M
Cibus3.79M
Connect Biopharma Holdings762.00K
Adagene103.20K
Revenue Rankings